Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | Sell | AbCellera Biologics, Inc. | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | AbCellera Biologics, Inc. | $313,000 | – | 29,411 | – | 100.00% | – |
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | Sell | AbCellera Biologics, Inc. | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | AbCellera Biologics, Inc. | $313,000 | – | 29,411 | – | 100.00% | – |